methacycline has been researched along with Weight Gain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albert, CJ; Brunt, EM; Chen, Z; Collier, SL; Finck, BN; Ford, DA; Graham, MJ; Hall, AM; Mathews, JC; Soufi, N; Yoshino, J | 1 |
| Bruce, CR; De Souza, DP; Hamley, S; Kloehn, J; Kowalski, GM; McConville, MJ; Nijagal, B; O'Callaghan, S; Selathurai, A; Tull, DL | 1 |
2 other study(ies) available for methacycline and Weight Gain
| Article | Year |
|---|---|
Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in mice.
Topics: Acyltransferases; Adipose Tissue; Adiposity; Animals; Biomarkers; Diet; Diglycerides; Fatty Acids; Fatty Liver; Gene Expression Regulation; Gene Knockdown Techniques; Glucose; Glucose Tolerance Test; Hepatic Stellate Cells; Homeostasis; Inflammation; Leukocytes; Lipogenesis; Liver; Male; Mice, Inbred C57BL; Mice, Obese; N-Acetylglucosaminyltransferases; Oligonucleotides, Antisense; Oxidation-Reduction; Triglycerides; Weight Gain | 2014 |
Reversing diet-induced metabolic dysregulation by diet switching leads to altered hepatic de novo lipogenesis and glycerolipid synthesis.
Topics: Animals; Blood Glucose; Diet, High-Fat; Dietary Fats; Diglycerides; Energy Intake; Fatty Acids; Glucose Intolerance; Glycolipids; Lipogenesis; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Triglycerides; Weight Gain | 2016 |